{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:21:07Z","timestamp":1790767267922,"version":"4.1.0"},"reference-count":121,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T00:00:00Z","timestamp":1594166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF18OC0053491"],"award-info":[{"award-number":["NNF18OC0053491"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cancer is a major challenge in our societies, according to the World Health Organization (WHO) about 1\/6 deaths were cancer related in 2018 and it is considered the second leading cause of death globally. Immunotherapies have changed the paradigm of oncologic treatment for several cancers where the field had fallen short in providing competent therapies. Despite the improvement, broadly acting and highly effective therapies capable of eliminating or preventing human cancers with insufficient mutated antigens are still missing. Adenoviral vector-based vaccines are a successful tool in the treatment of various diseases including cancer; however, their success has been limited. In this review we discuss the potential of adenovirus as therapeutic tools and the current developments to use them against cancer. More specifically, we examine how to use them to target endogenous retroviruses (ERVs). ERVs, comprising 8% of the human genome, have been detected in several cancers, while they remain silent in healthy tissues. Their low immunogenicity together with their immunosuppressive capacity aid cancer to escape immunosurveillance. In that regard, virus-like-vaccine (VLV) technology, combining adenoviral vectors and virus-like-particles (VLPs), can be ideal to target ERVs and elicit B-cell responses, as well as CD8+ and CD4+ T-cells responses.<\/jats:p>","DOI":"10.3390\/ijms21144843","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T10:45:19Z","timestamp":1594291519000},"page":"4843","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Cancer Associated Endogenous Retroviruses: Ideal Immune Targets for Adenovirus-Based Immunotherapy"],"prefix":"10.3390","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1966-2912","authenticated-orcid":false,"given":"Amaia","family":"Vergara Bermejo","sequence":"first","affiliation":[{"name":"InProTher, Bioinnovation Institute, Copenhagen Bio Science Park, 2200 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emeline","family":"Ragonnaud","sequence":"additional","affiliation":[{"name":"InProTher, Bioinnovation Institute, Copenhagen Bio Science Park, 2200 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7438-3222","authenticated-orcid":false,"given":"Joana","family":"Daradoumis","sequence":"additional","affiliation":[{"name":"InProTher, Bioinnovation Institute, Copenhagen Bio Science Park, 2200 Copenhagen, Denmark"},{"name":"Center for Medical Parasitology, Department of Immunology and Microbiology, University of Copenhagen, 2200 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1279-304X","authenticated-orcid":false,"given":"Peter","family":"Holst","sequence":"additional","affiliation":[{"name":"InProTher, Bioinnovation Institute, Copenhagen Bio Science Park, 2200 Copenhagen, Denmark"},{"name":"Center for Medical Parasitology, Department of Immunology and Microbiology, University of Copenhagen, 2200 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,7,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1001\/jama.2016.4218","article-title":"Safety and Immunogenicity of Novel Adenovirus Type 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines","volume":"315","author":"Milligan","year":"2016","journal-title":"JAMA"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Andersson, A.-M.M.C., Schwerdtfeger, M., and Holst, P.J. (2018). Virus-Like-Vaccines against HIV. Vaccines, 6.","DOI":"10.3390\/vaccines6010010"},{"key":"ref_3","unstructured":"(2020, June 01). World Health Organization. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41586-019-1671-8","article-title":"MHC-II neoantigens shape tumour immunity and response to immunotherapy","volume":"574","author":"Alspach","year":"2019","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/35057062","article-title":"Initial sequencing and analysis of the human genome","volume":"409","author":"Lander","year":"2001","journal-title":"Nature"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1073\/pnas.64.3.1087","article-title":"Oncogenes of RNA tumor viruses as determinants of cancer","volume":"64","author":"Huebner","year":"1969","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1126\/science.177.4043.60","article-title":"Inhibition of Chemical Carcinogenesis by Viral Vaccines","volume":"177","author":"Whitmire","year":"1972","journal-title":"Science"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1073\/pnas.78.4.2526","article-title":"Prevention of 3-methylcholanthrene-induced fibrosarcomas in rats pre-inoculated with endogenous rat retrovirus","volume":"78","author":"Fish","year":"1981","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"14920","DOI":"10.1073\/pnas.95.25.14920","article-title":"Tumor cells expressing a retroviral envelope escape immune rejection in vivo","volume":"95","author":"Mangeney","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1158\/0008-5472.CAN-04-4231","article-title":"Endogenous Retrovirus Expression Is Required for Murine Melanoma Tumor Growth In vivo","volume":"65","author":"Mangeney","year":"2005","journal-title":"Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e26889","DOI":"10.4161\/onci.26889","article-title":"Murine leukemia virus envelope gp70 is a shared biomarker for the high-sensitivity quantification of murine tumor burden","volume":"2","author":"Scrimieri","year":"2013","journal-title":"Oncoimmunology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.2408338","article-title":"A new class of endogenous human retroviral genomes","volume":"228","author":"Callahan","year":"1985","journal-title":"Science"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1742-4690-8-90","article-title":"Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses","volume":"8","author":"Subramanian","year":"2011","journal-title":"Retrovirology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"84093","DOI":"10.18632\/oncotarget.11455","article-title":"Activation of HERV-K Env protein is essential for tumorigenesis and metastasis of breast cancer cells","volume":"7","author":"Zhou","year":"2016","journal-title":"Oncotarget"},{"key":"ref_16","first-page":"1","article-title":"Expression of human endogenous retrovirus-K is strongly associated with the basal-like breast cancer phenotype","volume":"7","author":"Zheng","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1177\/1947601911431841","article-title":"Expression of Human Endogenous Retrovirus Type K Envelope Protein is a Novel Candidate Prognostic Marker for Human Breast Cancer","volume":"2","author":"Zhao","year":"2011","journal-title":"Genes Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/sj.onc.1206241","article-title":"Quantitation of HERV-K env gene expression and splicing in human breast cancer","volume":"22","author":"Frost","year":"2003","journal-title":"Oncogene"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ab.2008.09.002","article-title":"Identification of low-abundance alternatively spliced mRNA variants by exon exclusive reverse transcriptase polymerase chain reaction","volume":"383","author":"Wang","year":"2008","journal-title":"Anal. Biochem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1039\/C7SC00094D","article-title":"Highly sensitive and multiplexed quantification of mRNA splice variants by the direct ligation of DNA probes at the exon junction and universal PCR amplification","volume":"8","author":"Wang","year":"2017","journal-title":"Chem. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Lema\u00eetre, C., Tsang, J., Bireau, C., Heidmann, T., and Dewannieux, M. (2017). A human endogenous retrovirus-derived gene that can contribute to oncogenesis by activating the ERK pathway and inducing migration and invasion. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006451"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1158\/1078-0432.CCR-17-0001","article-title":"Downregulation of Human Endogenous Retrovirus Type K (HERV-K) Viral env RNA in Pancreatic Cancer Cells Decreases Cell Proliferation and Tumor Growth","volume":"23","author":"Li","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1158\/1078-0432.CCR-14-0388","article-title":"Cytotoxicity of human endogenous retrovirus K-specific T cells toward autologous ovarian cancer cells","volume":"21","author":"Rycaj","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_24","first-page":"81","article-title":"Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer","volume":"120","author":"Liu","year":"2006","journal-title":"Int. J. Cancer"},{"key":"ref_25","first-page":"51","article-title":"HERV-K Hypomethylation in Ovarian Clear Cell Carcinoma Is Associated with a Poor Prognosis and Platinum Resistance","volume":"21","author":"Triratanachat","year":"2010","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"E6642","DOI":"10.1073\/pnas.1702204114","article-title":"HEMO, an ancestral endogenous retroviral envelope protein shed in the blood of pregnant women and expressed in pluripotent stem cells and tumors","volume":"114","author":"Heidmann","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Agoni, L., Guha, C., and Lenz, J. (2013). Detection of Human Endogenous Retrovirus K (HERV-K) Transcripts in Human Prostate Cancer Cell Lines. Front. Oncol., 3.","DOI":"10.3389\/fonc.2013.00180"},{"key":"ref_28","first-page":"15","article-title":"Identification of the HERV-K gag antigen in prostate cancer by SEREX using autologous patient serum and its immunogenicity","volume":"8","author":"Ishida","year":"2008","journal-title":"Cancer Immun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1093\/carcin\/bgu114","article-title":"Elevated HERV-K mRNA expression in PBMC is associated with a prostate cancer diagnosis particularly in older men and smokers","volume":"35","author":"Wallace","year":"2014","journal-title":"Carcinogenesis"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1002\/pros.23095","article-title":"Human endogenous retrovirus HERV-K(HML-2) activity in prostate cancer is dominated by a few loci","volume":"75","author":"Goering","year":"2015","journal-title":"Prostate"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"6112","DOI":"10.1158\/1078-0432.CCR-12-3580","article-title":"Prostate cancer progression correlates with increased humoral immune response to a human endogenous retrovirus GAG protein","volume":"19","author":"Reis","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/sj.bjc.6690524","article-title":"DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas","volume":"80","author":"Florl","year":"1999","journal-title":"Br. J. Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ebiom.2019.01.063","article-title":"Integrated epigenomic profiling reveals endogenous retrovirus reactivation in renal cell carcinoma","volume":"41","author":"Siebenthall","year":"2019","journal-title":"EBioMedicine"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"9329","DOI":"10.1128\/JVI.00646-08","article-title":"Human Endogenous Retrovirus K (HML-2) Elements in the Plasma of People with Lymphoma and Breast Cancer","volume":"82","author":"Kaplan","year":"2008","journal-title":"J. Virol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1038\/leu.2013.8","article-title":"The viral oncogene Np9 acts as a critical molecular switch for co-activating \u03b2-catenin, ERK, Akt and Notch1 and promoting the growth of human leukemia stem\/progenitor cells","volume":"27","author":"Chen","year":"2013","journal-title":"Leukemia"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1158\/0008-5472.CAN-04-2983","article-title":"Expression of human endogenous retrovirus K in melanomas and melanoma cell lines","volume":"65","author":"Trefzer","year":"2005","journal-title":"Cancer Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/gbe\/evt010","article-title":"Transcriptional profiling of human endogenous retrovirus group HERV-K(HML-2) loci in melanoma","volume":"5","author":"Schmitt","year":"2013","journal-title":"Genome Biol. Evol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3389\/fmicb.2018.00211","article-title":"Elevated HERV-K Expression in Soft Tissue Sarcoma Is Associated with Worsened Relapse-Free Survival","volume":"9","author":"Giebler","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.18632\/oncotarget.679","article-title":"Reactivation of codogenic endogenous retroviral (ERV) envelope genes in human endometrial carcinoma and prestages: Emergence of new molecular targets","volume":"3","author":"Strissel","year":"2012","journal-title":"Oncotarget"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.micpath.2017.12.040","article-title":"Human endogenous retrovirus env genes: Potential blood biomarkers in lung cancer","volume":"115","author":"Zare","year":"2018","journal-title":"Microb. Pathog."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Liang, Q., Xu, Z., Xu, R., Wu, L., and Zheng, S. (2012). Expression Patterns of Non-Coding Spliced Transcripts from Human Endogenous Retrovirus HERV-H Elements in Colon Cancer. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0029950"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Ferrari, L., Cafora, M., Rota, F., Hoxha, M., Iodice, S., Tarantini, L., Dolci, M., Delbue, S., Pistocchi, A., and Bollati, V. (2019). Extracellular vesicles released by colorectal cancer cell lines modulate innate immune response in zebrafish model: The possible role of human endogenous retroviruses. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20153669"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ebiom.2017.02.025","article-title":"Identification of an atypical etiological head and neck squamous carcinoma subtype featuring the CpG island methylator phenotype","volume":"17","author":"Brennan","year":"2017","journal-title":"EBioMedicine"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"14152","DOI":"10.1073\/pnas.0606698103","article-title":"Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model","volume":"103","author":"Strati","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13014-016-0672-0","article-title":"Transcriptomic analyses of the radiation response in head and neck squamous cell carcinoma subclones with different radiation sensitivity: Time-course gene expression profiles and gene association networks","volume":"11","author":"Michna","year":"2016","journal-title":"Radiat. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1038\/onc.2013.366","article-title":"Mutations in 3\u2019-long terminal repeat of HERV-W family in chromosome 7 upregulate syncytin-1 expression in urothelial cell carcinoma of the bladder through interacting with c-Myb","volume":"33","author":"Yu","year":"2014","journal-title":"Oncogene"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Gosenca, D., Gabriel, U., Steidler, A., Mayer, J., Diem, O., Erben, P., Fabarius, A., Leib-M\u00f6sch, C., Hofmann, W.K., and Seifarth, W. (2012). HERV-E-Mediated Modulation of PLA2G4A Transcription in Urothelial Carcinoma. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0049341"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000495887","article-title":"Immune Checkpoint Human Endogenous Retrovirus-H Long Terminal Repeat-Associating Protein 2 is Upregulated and Independently Predicts Unfavorable Prognosis in Bladder Urothelial Carcinoma","volume":"141","author":"Lin","year":"2019","journal-title":"Nephron"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Panda, A., de Cubas, A.A., Stein, M., Riedlinger, G., Kra, J., Mayer, T., Smith, C.C., Vincent, B.G., Serody, J.S., and Beckermann, K.E. (2018). Endogenous retrovirus expression is associated with response to immune checkpoint pathway in clear cell renal cell carcinoma. JCI Insight, 3.","DOI":"10.1172\/jci.insight.121522"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12308-019-00352-0","article-title":"Human endogenous retrovirus, HERV-P and HERV-R in pediatric leukemia patients","volume":"12","author":"Bergallo","year":"2019","journal-title":"J. Hematop."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Maliniemi, P., Vincendeau, M., Mayer, J., Frank, O., Hahtola, S., Karenko, L., Carlsson, E., Mallet, F., Seifarth, W., and Leib-M\u00f6sch, C. (2013). Expression of Human Endogenous Retrovirus-W Including Syncytin-1 in Cutaneous T-Cell Lymphoma. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0076281"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000438669","article-title":"Human Endogenous Retrovirus Expression in Primary Cutaneous T-Cell Lymphomas","volume":"232","author":"Fava","year":"2016","journal-title":"Dermatology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12977-017-0342-9","article-title":"DNA hypomethylation and aberrant expression of the human endogenous retrovirus ERVWE1\/syncytin-1 in seminomas","volume":"14","author":"Hron","year":"2017","journal-title":"Retrovirology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.ygeno.2004.09.004","article-title":"Expression analyses of human endogenous retroviruses (HERVs): Tissue-specific and developmental stage-dependent expression of HERVs","volume":"84","author":"Okahara","year":"2004","journal-title":"Genomics"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s100380170012","article-title":"Search for active endogenous retroviruses: Identification and characterization of a HERV-E gene that is expressed in the pancreas and thyroid","volume":"46","author":"Shiroma","year":"2001","journal-title":"J. Hum. Genet."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13027-019-0260-7","article-title":"Evaluating the expression level of HERV-K env, np9, rec and gag in breast tissue","volume":"14","author":"Tavakolian","year":"2019","journal-title":"Infect. Agent. Cancer"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1006\/viro.2002.1428","article-title":"Developmental Expression of HERV-R (ERV3) and HERV-K in Human Tissue","volume":"297","author":"Andersson","year":"2002","journal-title":"Virology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1128\/JVI.74.7.3321-3329.2000","article-title":"An Envelope Glycoprotein of the Human Endogenous Retrovirus HERV-W Is Expressed in the Human Placenta and Fuses Cells Expressing the Type D Mammalian Retrovirus Receptor","volume":"74","author":"Blond","year":"2000","journal-title":"J. Virol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/35001608","article-title":"Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis","volume":"403","author":"Mi","year":"2000","journal-title":"Nature"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Lokossou, A.G., Toudic, C., Nguyen, P.T., Elisseeff, X., Vargas, A., Rassart, \u00c9., Lafond, J., Leduc, L., Bourgault, S., and Gilbert, C. (2019). Endogenous retrovirus-encoded Syncytin-2 contributes to exosome-mediated immunosuppression of T cells. Biol. Reprod.","DOI":"10.1093\/biolre\/ioz124"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1742-4690-9-67","article-title":"Single mutations in the transmembrane envelope protein abrogate the immunosuppressive property of HIV-1","volume":"9","author":"Morozov","year":"2012","journal-title":"Retrovirology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1128\/jvi.64.6.2608-2619.1990","article-title":"Mechanism of escape of endogenous murine leukemia virus emv-14 from recognition by anti-AKR\/Gross virus cytolytic T lymphocytes","volume":"64","author":"White","year":"1990","journal-title":"J. Virol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2249.1992.tb06884.x","article-title":"Distribution of retroviral p15E-related proteins in neoplastic and non-neoplastic human tissues, and their role in the regulation of the immune response","volume":"89","author":"Scheeren","year":"1992","journal-title":"Clin. Exp. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Morozov, V.A., Dao Thi, V.L., and Denner, J. (2013). The Transmembrane Protein of the Human Endogenous Retrovirus-K (HERV-K) Modulates Cytokine Release and Gene Expression. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0070399"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1158\/0008-5472.CAN-13-1349","article-title":"Induction of immunoregulatory CD271+ cells by metastatic tumor cells that express human endogenous retrovirus H","volume":"74","author":"Yura","year":"2014","journal-title":"Cancer Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1365-2273.1993.tb00857.x","article-title":"Retroviral p15E-related serum factors and recurrence of head and neck cancer","volume":"18","author":"Tas","year":"1993","journal-title":"Clin. Otolaryngol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF00179016","article-title":"Immunosuppressive retroviral-related factors in sera of patients with head and neck cancer","volume":"247","author":"Tan","year":"1990","journal-title":"Eur. Arch. Oto-Rhino-Laryngol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/019459988709600304","article-title":"Immunohistochemical Detection of Retroviral\u2014P15E\u2014Related Material in Carcinomas of the Head and Neck","volume":"96","author":"Tan","year":"1987","journal-title":"Otolaryngol. Neck Surg."},{"key":"ref_69","first-page":"1831","article-title":"New monoclonal antibodies against the putative immunosuppressive site of retroviral p15E","volume":"54","author":"Lang","year":"1994","journal-title":"Cancer Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/eji.201445366","article-title":"Human endogenous retrovirus envelope proteins target dendritic cells to suppress T-cell activation","volume":"45","author":"Hummel","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"5893","DOI":"10.1073\/pnas.84.16.5893","article-title":"Role of antibodies to murine leukemia virus p15E transmembrane protein in immunotherapy against AKR leukemia: A model for studies in human acquired immunodeficiency syndrome","volume":"84","author":"Thiel","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"6396","DOI":"10.4049\/jimmunol.171.12.6396","article-title":"Effective Genetic Vaccination with a Widely Shared Endogenous Retroviral Tumor Antigen Requires CD40 Stimulation during Tumor Rejection Phase","volume":"171","author":"Bronte","year":"2003","journal-title":"J. Immunol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/cimm.2000.1691","article-title":"Anti-tumor immunity against CT26 colon tumor in mice immunized with plasmid DNA encoding \u03b2-galactosidase fused to an envelope protein of endogenous retrovirus","volume":"204","author":"Takeda","year":"2000","journal-title":"Cell. Immunol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.4049\/jimmunol.169.7.3908","article-title":"Critical Components of a DNA Fusion Vaccine Able to Induce Protective Cytotoxic T Cells Against a Single Epitope of a Tumor Antigen","volume":"169","author":"Rice","year":"2002","journal-title":"J. Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/jnci\/djr540","article-title":"Immunotherapeutic potential of anti-human endogenous retrovirus-k envelope protein antibodies in targeting breast tumors","volume":"104","author":"Rycaj","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Kraus, B., Fischer, K., B\u00fcchner, S.M., Wels, W.S., L\u00f6wer, R., Sliva, K., and Schnierle, B.S. (2013). Vaccination Directed against the Human Endogenous Retrovirus-K Envelope Protein Inhibits Tumor Growth in a Murine Model System. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0072756"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1743-422X-11-58","article-title":"Vaccination directed against the human endogenous retrovirus-K (HERV-K) gag protein slows HERV-K gag expressing cell growth in a murine model system","volume":"11","author":"Kraus","year":"2014","journal-title":"Virol. J."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e1047582","DOI":"10.1080\/2162402X.2015.1047582","article-title":"Chimeric antigen receptor T cells targeting HERV-K inhibit breast cancer and its metastasis through downregulation of Ras","volume":"4","author":"Zhou","year":"2015","journal-title":"Oncoimmunology"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1158\/1078-0432.CCR-14-3197","article-title":"Genetic Engineering of T Cells to Target HERV-K, an Ancient Retrovirus on Melanoma","volume":"21","author":"Krishnamurthy","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1128\/JVI.02192-06","article-title":"Innate Immune Response to Adenoviral Vectors Is Mediated by both Toll-Like Receptor-Dependent and -Independent Pathways","volume":"81","author":"Zhu","year":"2007","journal-title":"J. Virol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1073\/pnas.86.10.3823","article-title":"Role of early region 3 (E3) in pathogenesis of adenovirus disease","volume":"86","author":"Ginsberg","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ymthe.2004.07.013","article-title":"Adenoviruses as vaccine vectors","volume":"10","author":"Tatsis","year":"2004","journal-title":"Mol. Ther."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1128\/JVI.80.4.1959-1964.2006","article-title":"Protection of Mice and Poultry from Lethal H5N1 Avian Influenza Virus through Adenovirus-Based Immunization","volume":"80","author":"Gao","year":"2006","journal-title":"J. Virol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1086\/509258","article-title":"Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV-1 Candidate Vaccine Delivered by a Replication-Defective Recombinant Adenovirus Vector","volume":"194","author":"Catanzaro","year":"2006","journal-title":"J. Infect. Dis."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.4049\/jimmunol.1502672","article-title":"Prime-Boost Immunization Eliminates Metastatic Colorectal Cancer by Producing High-Avidity Effector CD8+ T Cells","volume":"198","author":"Xiang","year":"2017","journal-title":"J. Immunol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/35046108","article-title":"Development of a preventive vaccine for Ebola virus infection in primates","volume":"408","author":"Sullivan","year":"2000","journal-title":"Nature"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Yin, X., Langer, S., Zhang, Z., Herbert, K.M., Yoh, S., K\u00f6nig, R., and Chanda, S.K. (2020). Sensor Sensibility\u2014HIV-1 and the Innate Immune Response. Cells, 9.","DOI":"10.3390\/cells9010254"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/vaccines8010139","article-title":"Recent progress on the versatility of virus-like particles","volume":"8","author":"Qian","year":"2020","journal-title":"Vaccines"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: A matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1158\/1535-7163.MCT-07-0483","article-title":"Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer","volume":"7","author":"Li","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/CJI.0b013e318209ee72","article-title":"Chimeric Trop2 Virus-like Particles","volume":"34","author":"Cubas","year":"2011","journal-title":"J. Immunother."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1182\/blood-2004-05-1952","article-title":"Uptake and presentation of hepatitis C virus-like particles by human dendritic cells","volume":"105","author":"Barth","year":"2005","journal-title":"Blood"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/B978-0-12-407190-2.00007-1","article-title":"Therapeutic Cancer Vaccines","volume":"119","author":"Guo","year":"2013","journal-title":"Adv. Cancer Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/CJI.0b013e3182787f5e","article-title":"Antigen Incorporated In Virus-like Particles Is Delivered to Specific Dendritic Cell Subsets That Induce An Effective Antitumor Immune Response In Vivo","volume":"36","author":"Li","year":"2013","journal-title":"J. Immunother."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1128\/JVI.01840-09","article-title":"Vaccination with an Adenoviral Vector That Encodes and Displays a Retroviral Antigen Induces Improved Neutralizing Antibody and CD4+ T-Cell Responses and Confers Enhanced Protection","volume":"84","author":"Bayer","year":"2010","journal-title":"J. Virol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.4049\/jimmunol.1102756","article-title":"The Thai Phase III Trial (RV144) Vaccine Regimen Induces T Cell Responses That Preferentially Target Epitopes within the V2 Region of HIV-1 Envelope","volume":"188","author":"Chuenarom","year":"2012","journal-title":"J. Immunol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"7881","DOI":"10.1016\/j.vaccine.2010.09.079","article-title":"Comparison of T cell immune responses induced by vectored HIV vaccines in non-human primates and humans","volume":"28","author":"Bett","year":"2010","journal-title":"Vaccine"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/14760584.2020.1711054","article-title":"The potential of adenoviral vaccine vectors with altered antigen presentation capabilities","volume":"19","author":"Neukirch","year":"2020","journal-title":"Expert Rev. Vaccines"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/2051013613480446","article-title":"The rationale of vectored gene-fusion vaccines against cancer: Evolving strategies and latest evidence","volume":"1","author":"Ragonnaud","year":"2013","journal-title":"Ther. Adv. Vaccines"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-016-1102-7","article-title":"Increased t cell breadth and antibody response elicited in prime-boost regimen by viral vector encoded homologous siv gag\/env in outbred cd1 mice","volume":"14","author":"Andersson","year":"2016","journal-title":"J. Transl. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12967-019-1924-1","article-title":"Virus-like vaccines against HIV\/SIV synergize with a subdominant antigen T cell vaccine","volume":"17","author":"Schwerdtfeger","year":"2019","journal-title":"J. Transl. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.molcel.2016.03.029","article-title":"Long Terminal Repeats: From Parasitic Elements to Building Blocks of the Transcriptional Regulatory Repertoire","volume":"62","author":"Thompson","year":"2016","journal-title":"Mol. Cell"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1101\/gad.252767.114","article-title":"The KRAB zinc finger protein ZFP809 is required to initiate epigenetic silencing of endogenous retroviruses","volume":"29","author":"Wolf","year":"2015","journal-title":"Genes Dev."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"7187","DOI":"10.1128\/JVI.00544-15","article-title":"Human Endogenous Retrovirus Type K (HERV-K) Particles Package and Transmit HERV-K\u2014Related Sequences","volume":"89","author":"Kaplan","year":"2015","journal-title":"J. Virol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1099\/vir.0.83534-0","article-title":"Human endogenous retrovirus HERV-K113 is capable of producing intact viral particles","volume":"89","author":"Boller","year":"2008","journal-title":"J. Gen. Virol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nri.2016.27","article-title":"Immune responses to endogenous retroelements: Taking the bad with the good","volume":"16","author":"Kassiotis","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Stanley, M. (2017). Tumour virus vaccines: Hepatitis B virus and human papillomavirus. Philos. Trans. R. Soc. B Biol. Sci., 372.","DOI":"10.1098\/rstb.2016.0268"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.coi.2016.05.014","article-title":"Viral vectors as vaccine platforms: From immunogenicity to impact","volume":"41","author":"Ewer","year":"2016","journal-title":"Curr. Opin. Immunol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.4049\/jimmunol.180.5.3339","article-title":"MHC Class II-Associated Invariant Chain Linkage of Antigen Dramatically Improves Cell-Mediated Immunity Induced by Adenovirus Vaccines","volume":"180","author":"Holst","year":"2008","journal-title":"J. Immunol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1002\/eji.200939543","article-title":"Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4+ T-cell-independent CD8+ T-cell-mediated tumor control","volume":"39","author":"Sorensen","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/CJI.0000000000000153","article-title":"Therapeutic Vaccine Against Primate Papillomavirus Infections of the Cervix","volume":"40","author":"Ragonnaud","year":"2017","journal-title":"J. Immunother."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/S0618-8278(19)30005-2","article-title":"GS-05-MHC-II invariant chain adjuvanted chimpanzee adenoviral and MVA hepatitis C vaccines elicit unprecedented levels of anti-viral T-cell immune responses in humans","volume":"70","author":"Esposito","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"15020","DOI":"10.1038\/s41598-018-33375-1","article-title":"Development of a Molecular Adjuvant to Enhance Antigen-Specific CD8+ T Cell Responses","volume":"8","author":"Halbroth","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1038\/mt.2014.130","article-title":"Co-Expression of Tumor Antigen and Interleukin-2 From an Adenoviral Vector Augments the Efficiency of Therapeutic Tumor Vaccination","volume":"22","author":"Jensen","year":"2014","journal-title":"Mol. Ther."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/j.vaccine.2015.06.087","article-title":"An adenoviral cancer vaccine co-encoding a tumor associated antigen together with secreted 4-1BBL leads to delayed tumor progression","volume":"34","author":"Ragonnaud","year":"2016","journal-title":"Vaccine"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.18632\/oncotarget.26680","article-title":"Adenovirus based virus-like-vaccines targeting endogenous retroviruses can eliminate growing colorectal cancers in mice","volume":"10","author":"Neukirch","year":"2019","journal-title":"Oncotarget"},{"key":"ref_117","first-page":"1","article-title":"Adenoviral vaccine targeting multiple neoantigens as strategy to eradicate large tumors combined with checkpoint blockade","volume":"10","author":"Leoni","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41541-019-0103-y","article-title":"Turning the corner on therapeutic cancer vaccines","volume":"4","author":"Hollingsworth","year":"2019","journal-title":"NPJ Vaccines"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41571-019-0175-7","article-title":"Regulatory T cells in cancer immunosuppression\u2014Implications for anticancer therapy","volume":"16","author":"Togashi","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Saleh, R., and Elkord, E. (2019). Acquired resistance to cancer immunotherapy: Role of tumor-mediated immunosuppression. Semin. Cancer Biol.","DOI":"10.1016\/j.semcancer.2019.07.017"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/jgm.1629","article-title":"High-capacity adenoviral vectors circumvent the limitations of \u0394E1 and \u0394E1\/\u0394E3 adenovirus vectors to induce multispecific transgene product-directed CD8 T-cell responses","volume":"13","author":"Kron","year":"2011","journal-title":"J. Gene Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/14\/4843\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:49:09Z","timestamp":1760176149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/14\/4843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,8]]},"references-count":121,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2020,7]]}},"alternative-id":["ijms21144843"],"URL":"https:\/\/doi.org\/10.3390\/ijms21144843","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,8]]}}}